McBride (LON:MCB) had its price target decreased by Liberum Capital from GBX 260 ($3.53) to GBX 235 ($3.19) in a research note issued on Monday. The firm currently has a “buy” rating on the stock. Liberum Capital’s price target suggests a potential upside of 30.80% from the company’s current price.
MCB has been the topic of a number of other reports. Numis Securities raised their price objective on McBride from GBX 235 ($3.19) to GBX 260 ($3.53) and gave the company a “buy” rating in a report on Wednesday, October 4th. Berenberg Bank raised their price objective on McBride from GBX 220 ($2.98) to GBX 240 ($3.25) and gave the company a “buy” rating in a report on Friday, September 29th. Finally, Peel Hunt cut McBride to a “hold” rating and set a GBX 215 ($2.92) price objective on the stock. in a report on Wednesday, October 11th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of GBX 230.83 ($3.13).
Shares of McBride (LON MCB) opened at GBX 179.67 ($2.44) on Monday. The firm has a market capitalization of $327.38 and a PE ratio of 3,593.40. McBride has a 1-year low of GBX 158.31 ($2.15) and a 1-year high of GBX 235 ($3.19).
McBride plc is a provider of private label household and personal care products. The Company is engaged in developing, producing and supplying its products to retailers across Europe. Its segments include Household, Personal Care & Aerosols (PCA) and Corporate. The Household segment consists of UK; North, including France, Belgium, Holland and Scandinavia; South, including Italy and Spain, and East, including Germany, Poland, Luxembourg and other Eastern Europe.
Receive News & Ratings for McBride Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McBride and related companies with MarketBeat.com's FREE daily email newsletter.